Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities      
Net Income (Loss) $ 8,034 $ 9,770 $ (12,634)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 3,950 2,631 1,099
Equity-based compensation 10,641 5,187 7,079
Loss from equity method investments in affiliates 98    
Provision for credit losses     11,000
Gain on sale of financing receivables and investments (6,993) (6,796) (390)
Changes in financing receivables held-for-sale 11,002 25 (16,444)
Changes in accounts payable and accrued expenses (1,029) (3,201) 498
Other (7,184) (2,493) (960)
Net cash provided by (used in) operating activities 18,519 5,123 (10,752)
Cash flows from investing activities      
Purchases of financing receivables (289,906) (227,075) (155,992)
Principal collections from financing receivables 70,093 67,815 68,537
Proceeds from sales of financing receivables 92,456 30,433  
Purchases of investments (33,648) (7,753) (92,522)
Principal collections from investments 8,919 1,784 558
Proceeds from sales of investments 21,995 75,179  
Acquisition of businesses, net of cash   (125,925)  
Purchases of real estate (42,913) (27,624)  
Investments in equity method affiliate, net (200,271) (144,770)  
Distributions received from equity method affiliates 25,307 867  
Change in restricted cash (12,035) 37,922 (49,810)
Other (1,078) (134) (65)
Net cash used in investing activities (361,081) (319,281) (229,294)
Cash flows from financing activities      
Proceeds from credit facility 308,086 310,501 131,000
Principal payments on credit facility (376,455) (72,100) (57,974)
Proceeds from nonrecourse debt 405,765 115,316 129,122
Principal payments on nonrecourse debt (46,602) (55,570) (65,231)
Payments on deferred funding obligations (82,838) (67,354) (16,874)
Net proceeds of common stock issuances 180,486 129,351 160,031
Payment of dividends and distributions (31,591) (13,864) (7,128)
Other (29,843) (5,769) (9,078)
Net cash provided by financing activities 327,008 340,511 263,868
(Decrease) increase in cash and cash equivalents (15,554) 26,353 23,822
Cash and cash equivalents at beginning of period 58,199 31,846 8,024
Cash and cash equivalents at end of period 42,645 58,199 31,846
Interest paid $ 24,111 $ 13,213 $ 8,864